About Zana Technologies
Zana Technologies is a deep tech healthcare company based in Germany, founded in 2018. The company leverages voice and AI technology to transform healthcare, focusing on digital patient companions and extracting digital voice biomarkers to evaluate health status and well-being, similar to traditional biological markers like pulse or temperature.
Mission and Solutions
Zana's AI-powered voice technology supports better health and care across respiratory diseases such as asthma and COPD, as well as cardiology including heart failure. Their platform enables pharmaceutical companies, telemonitoring providers, and MedTech companies to digitize clinical trials, advance remote monitoring, and detect health issues early to prevent hospitalization and improve patient lives.
They develop AI-as-a-Service platforms that analyze voice recordings collected via mobile apps or call centers, using AI to recognize voice patterns associated with health outcomes. The analyzed results are delivered through desired systems or APIs.
Key Highlights and Values
- Clinical study for voice biomarkers in heart failure reaching over 100 patients
- Strategic partnerships with university medical centers and clinical research organizations
- Medical Device CE Mark for AI-driven health monitoring platform
- ISO 13485 certification, demonstrating commitment to medical device quality standards
- Focus on ethical use of AI and data to drive positive societal change
Zana has an international team with expertise in technology development, R&D, business development, and regulatory compliance, led by co-founders Dr.-Ing. Julia Hoxha (CEO) and Dr. Armand Brahaj (CTO).
Contact and Locations
Headquarters: Karlsruhe, Germany
Office: Berlin, Germany